Simcere Pharmaceutical Group Limited (2096.HK)

HKD 8.74

(2.1%)

Net Income Summary of Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited's latest annual net income in 2023 was 714.76 Million CNY , down -23.22% from previous year.
Simcere Pharmaceutical Group Limited's latest quarterly net income in 2024 Q2 was 228.3 Million CNY , down 0.0% from previous quarter.
Simcere Pharmaceutical Group Limited reported an annual net income of 930.86 Million CNY in 2022, down -38.23% from previous year.
Simcere Pharmaceutical Group Limited reported an annual net income of 1.5 Billion CNY in 2021, up 125.1% from previous year.
Simcere Pharmaceutical Group Limited reported a quarterly net income of 228.3 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Simcere Pharmaceutical Group Limited reported a quarterly net income of -779.94 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Simcere Pharmaceutical Group Limited (2023 - 2012)

Historical Annual Net Income of Simcere Pharmaceutical Group Limited (2023 - 2012)

Year	Net Income	Net Income Growth
2023	714.76 Million CNY	-23.22%
2022	930.86 Million CNY	-38.23%
2021	1.5 Billion CNY	125.1%
2020	669.53 Million CNY	-33.29%
2019	1 Billion CNY	36.79%
2018	733.68 Million CNY	109.38%
2017	350.4 Million CNY	0.0%
2012	56.95 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q1	228.3 Million CNY	129.27%
2024 Q2	228.3 Million CNY	0.0%
2023 Q4	-779.94 Million CNY	0.0%
2023 FY	714.76 Million CNY	-23.22%
2023 Q1	1.13 Billion CNY	162.33%
2023 Q2	1.13 Billion CNY	0.0%
2023 Q3	-779.94 Million CNY	-168.58%
2022 Q1	31.89 Million CNY	-93.28%
2022 FY	930.86 Million CNY	-38.23%
2022 Q4	433.54 Million CNY	0.0%
2022 Q3	433.54 Million CNY	1259.41%
2022 Q2	31.89 Million CNY	0.0%
2021 Q3	474.64 Million CNY	70.18%
2021 FY	1.5 Billion CNY	125.1%
2021 Q1	278.9 Million CNY	15.25%
2021 Q2	278.9 Million CNY	0.0%
2021 Q4	474.64 Million CNY	0.0%
2020 Q4	242 Million CNY	0.0%
2020 FY	669.53 Million CNY	-33.29%
2020 Q1	92.75 Million CNY	-65.81%
2020 Q2	92.75 Million CNY	0.0%
2020 Q3	242 Million CNY	160.9%
2019 Q2	230.5 Million CNY	0.0%
2019 Q1	230.5 Million CNY	0.0%
2019 Q4	271.3 Million CNY	0.0%
2019 FY	1 Billion CNY	36.79%
2019 Q3	271.3 Million CNY	17.7%
2018 FY	733.68 Million CNY	109.38%
2017 FY	350.4 Million CNY	0.0%
2013 Q1	29.94 Million CNY	243.96%
2013 Q2	8.22 Million CNY	-72.52%
2013 Q3	166.95 Million CNY	1929.16%
2012 Q1	35.26 Million CNY	0.0%
2012 Q2	32.91 Million CNY	-6.67%
2012 Q3	15.98 Million CNY	-51.43%
2012 Q4	-20.8 Million CNY	-230.09%
2012 FY	56.95 Million CNY	0.0%

Peer Net Income Comparison of Simcere Pharmaceutical Group Limited

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	-908.467%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	-4043.542%